Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
J Pharm Biomed Anal ; 177: 112872, 2020 Jan 05.
Artigo em Inglês | MEDLINE | ID: mdl-31525574

RESUMO

It is often reported that falsified medicines have harmful effects on patients both Japan and abroad. In this study, we purchased vardenafil tablets on the internet and investigated their quality and authenticity using visual observations, authenticity investigations, non-destructive tests (handheld NIR and Raman spectroscopy), and quality analyses (active ingredient content and tablet dissolution rate). We used genuine 20-mg Levitra tablets that were sold in Japan and tablets from Bayer AG (Germany) as controls. In April 2015, we obtained 28 samples from 15 websites on the internet. Our authenticity investigations revealed that 11 (40%) were genuine products and 17 (60%) were falsified products. Handheld NIR and Raman results revealed that the falsified products had different spectra to the genuine products. Principal component analysis of the NIR and Raman spectra showed variation among the falsified products. The 11 genuine products were of good quality, and the 17 falsified products were of poor quality. The falsified products contained sildenafil (the active ingredient of Viagra) or tadalafil (the active ingredient of Cialis) instead of vardenafil. Our results show that falsified Vardenafil tablets are sold on the internet and that it is important to prevent illegal internet sales and increase consumer awareness of the presence of falsified medicines.


Assuntos
Medicamentos Falsificados/análise , Disponibilidade de Medicamentos Via Internet/normas , Controle de Qualidade , Agentes Urológicos/análise , Dicloridrato de Vardenafila/análise , Medicamentos Falsificados/química , Medicamentos Falsificados/economia , Humanos , Japão , Disponibilidade de Medicamentos Via Internet/economia , Análise de Componente Principal , Citrato de Sildenafila/análise , Análise Espectral Raman , Comprimidos , Tadalafila/análise , Agentes Urológicos/química , Agentes Urológicos/economia , Agentes Urológicos/normas , Dicloridrato de Vardenafila/química
2.
Eur J Clin Pharmacol ; 74(3): 349-356, 2018 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-29198063

RESUMO

PURPOSE: Gamma-hydroxybutyrate (GHB) withdrawal is a life-threatening condition that does not always respond to standard treatment with benzodiazepines. Baclofen has potential utility as a pharmacological adjunct and anecdotal reports suggest that it is being used by drug users to self-manage GHB withdrawal symptoms. Here, we investigate current patterns of use and the online availably of baclofen. METHODS: Data triangulation techniques were applied to published scientific literature and publicly accessible Internet resources (grey literature) to assess the use of baclofen in GHB withdrawal. An Internet snapshot survey was performed to identify the availability of baclofen for online purchase and the compliance of retailers with the UK regulations. Data were collected according to pre-defined criteria. RESULTS: A total of 37 cases of baclofen use in GHB withdrawal were identified in the scientific literature, as well as 51 relevant discussion threads across eight Internet forums in the grey literature. Baclofen was available to purchase from 38 online pharmacies, of which only one conformed to the UK regulations. CONCLUSIONS: There is limited published evidence on the use of baclofen in GHB withdrawal, but both scientific and grey literature suggests clinical utility. Online pharmacies are readily offering prescription-only-medication without prescription and due to inadequate regulation, pose a danger to the public.


Assuntos
Baclofeno/uso terapêutico , Agonistas dos Receptores de GABA-B/uso terapêutico , Internet , Padrões de Prática Médica , Psicotrópicos/toxicidade , Oxibato de Sódio/toxicidade , Síndrome de Abstinência a Substâncias/tratamento farmacológico , Animais , Baclofeno/economia , Baclofeno/normas , Baclofeno/provisão & distribuição , Pesquisa Biomédica/métodos , Tráfico de Drogas/economia , Agonistas dos Receptores de GABA-B/economia , Agonistas dos Receptores de GABA-B/normas , Agonistas dos Receptores de GABA-B/provisão & distribuição , Humanos , Internet/economia , Internet/ética , Disponibilidade de Medicamentos Via Internet/economia , Disponibilidade de Medicamentos Via Internet/ética , Disponibilidade de Medicamentos Via Internet/normas , Medicamentos sob Prescrição/economia , Medicamentos sob Prescrição/normas , Medicamentos sob Prescrição/provisão & distribuição , Medicamentos sob Prescrição/uso terapêutico , Mídias Sociais/economia , Mídias Sociais/ética , Reino Unido
3.
J Affect Disord ; 193: 59-65, 2016 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-26766033

RESUMO

BACKGROUND: There is increasing use of online pharmacies to purchase prescription drugs. While some online pharmacies are legitimate and safe, there are many unsafe and illegal so-called "rogue" online pharmacies. This study investigated the availability of psychotropic drugs online to consumers in the US, using 5 commonly prescribed drugs for bipolar disorder. METHODS: Using the search term "buy [drug name]" in the Google, Yahoo and Bing search engines, the characteristics of the online pharmacies found on the first two pages of search results were investigated. The availability of the requested dosage and formulations of two brand (Seroquel XR, Abilify) and three generic drugs (lamotrigine, lithium carbonate and bupropion SR) were determined. RESULTS: Of 30 online pharmacies found, 17 (57%) were rated as rogue by LegitScript. Of the 30 pharmacies, 15 (50%) require a prescription, 21 (70%) claim to be from Canada, with 20 of these having a Canadian International Pharmacy association (CIPA) seal on the website. Only 13 of the 20 sites with a CIPA seal were active CIPA members. There were about the same number of trust verification seals on the rogue and legitimate pharmacy sites. Some rogue pharmacies are professional in appearance, and may be difficult for consumers to recognize as rogue. All five brand and generic drugs were offered for sale online, with or without a prescription. However, many substitutions were presented such as different strengths and formulations including products not approved by the FDA. LIMITATIONS: No evaluation of product quality, packaging or purchasing. CONCLUSIONS: Psychotropic medications are available online with or without a prescription. The majority of online pharmacy websites were rogue. Physicians should ask about the use of online pharmacies. For those who choose to use online pharmacies, two measures to detect rogue pharmacies are recommended: (1) only purchase drugs from pharmacies that require a prescription, and (2) check all pharmacy verification seals directly on the website of the certifying organization, every time, before purchase.


Assuntos
Transtorno Bipolar/tratamento farmacológico , Disponibilidade de Medicamentos Via Internet/estatística & dados numéricos , Medicamentos sob Prescrição/provisão & distribuição , Psicotrópicos/provisão & distribuição , Canadá , Prescrições de Medicamentos/estatística & dados numéricos , Humanos , Disponibilidade de Medicamentos Via Internet/legislação & jurisprudência , Disponibilidade de Medicamentos Via Internet/normas , Medicamentos sob Prescrição/uso terapêutico , Psicotrópicos/uso terapêutico , Estados Unidos
5.
Int J Clin Pharm ; 37(1): 148-58, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25564180

RESUMO

BACKGROUND: Evidence suggests that consumers potentially put themselves at risk when purchasing medicines on-line. Whilst logos provided by regulators may provide some level of reassurance there may be other indicators which could be used by consumers to identify those websites which may be safely used. OBJECTIVES: Identify characteristics of on-line pharmacies which are related to whether websites are regulated or non-regulated and those characteristics which could be used by patients to increase the likelihood of accessing regulated sites. SETTING: Online pharmacies which supply diazepam, fluoxetine and simvastatin. METHODS: Using piloted search terms via Google and Yahoo search engines, identified websites were screened for regulatory status, adherence to regulatory standards, administrative requirements, clinical assessment requirements and additional details deemed to be of relevance to a user. Characteristics of regulated and non-regulated (defined as those with an absence of a correctly linked regulatory logo) websites were compared to identify differences which could be used to improve patient safety. MAIN OUTCOME MEASURE: Regulatory status, adherence to regulatory standards, quality of information provision, barriers to medicines access. RESULTS: 113 websites sold diazepam, fluoxetine and simvastatin; were identified within the first 100 results. Less than quarter were found to be regulated online pharmacies. 80 websites were willing to sell the medication without a prescription. The unregulated internet pharmacy websites (defined as those with an absence of a correctly linked regulatory logo) were found to adhere more closely to the clinical criteria, were less significantly likely to disclose a contact name and address, telephone number of the pharmacy or demand a prescription prior to sale (P < 0.05, Fisher's Exact). CONCLUSIONS: The three prescription-only medicines which are liable to abuse, have potentially serious interactions and require counselling to ensure patient safety are readily available via the internet. When purchasing medicines via this route UK consumers should be made aware of the importance of regulatory logos and additionally should ensure that the seller can be meaningfully contacted by the contact details provided. The provision of clinical information should not be used alone as an indication of the seller's provenance.


Assuntos
Internet/normas , Segurança do Paciente/normas , Disponibilidade de Medicamentos Via Internet/normas , Medicamentos sob Prescrição/normas , Humanos , Internet/economia , Segurança do Paciente/economia , Disponibilidade de Medicamentos Via Internet/economia , Projetos Piloto , Medicamentos sob Prescrição/economia , Reino Unido/epidemiologia
6.
Drug Alcohol Depend ; 130(1-3): 238-40, 2013 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-23201172

RESUMO

BACKGROUND: Use of illicit buprenorphine is increasingly recognized, but it is unknown if the Internet currently represents an accessible source. METHODS: A series of Internet searches were conducted. Twenty searches were performed on two different search engines. The first 100 results of each search were classified into categories based on content. All Internet pharmacies were searched for buprenorphine preparations and if available, sites were examined to determine if a prescription was required for purchase, for the cost of buprenorphine, the geographical origin of the pharmacy, and evidence of validation by an online pharmacy verification service. RESULTS: Of the 2000 links examined, 1422 were unique. Six percent of links were to illicit commercial sites, 2% were to legitimate commercial sites, and 2% were to illicit portal sites, which contained links to many illicit commercial sites. Twenty pharmacies offering buprenorphine for purchase without a prescription were identified. The monthly cost of a typical starting dose of 2 mg buprenorphine daily ranged between $232 and $1163 USD. No pharmacies were listed by online pharmacy verification services. CONCLUSION: Twenty online pharmacies advertising buprenorphine formulations for sale without a prescription were identified. Prices varied widely between illicit pharmacies but were uniformly more expensive than legitimate pharmacies. Illicitly obtained buprenorphine formulations appear to be relatively inaccessible and at high cost on the Internet.


Assuntos
Analgésicos Opioides/economia , Buprenorfina/economia , Prescrições de Medicamentos/economia , Internet/economia , Disponibilidade de Medicamentos Via Internet/economia , Disponibilidade de Medicamentos Via Internet/legislação & jurisprudência , Analgésicos Opioides/normas , Buprenorfina/normas , Prescrições de Medicamentos/normas , Controle de Medicamentos e Entorpecentes/legislação & jurisprudência , Controle de Medicamentos e Entorpecentes/métodos , Humanos , Internet/normas , Disponibilidade de Medicamentos Via Internet/normas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA